v3.26.1
Asset Acquisitions - Schedule of Consideration Paid and Allocation of Purchase Price for Acquisition (Details) - Bluejay Therapeutics, Inc.
$ in Thousands
Jan. 23, 2026
USD ($)
Asset Acquisitions [Line Items]  
Equity consideration $ 415,271
Equity holdback - indemnity 47,112
Cash consideration, including cash paid in lieu of equity to satisfy taxes 274,814
Cash holdback - indemnity 23,721
Cash holdback - working capital 957
Transaction costs 9,201
Total purchase consideration 771,076
IPR&D 724,006
Assembled workforce 2,296
Cash and cash equivalents 54,335
Prepaid expenses and other current assets 4,258
Operating lease right-of-use asset 1,113
Other non-current assets 3,888
Total assets acquired 789,896
Accounts payable 1,589
Accrued expenses and other current liabilities 16,616
Operating lease liabilities, noncurrent 615
Total liabilities assumed 18,820
Net assets acquired 771,076
Share-Based Payment Arrangement  
Asset Acquisitions [Line Items]  
Equity consideration 10,643
Equity holdback - indemnity 2,143
Cash consideration, including cash paid in lieu of equity to satisfy taxes 20,742
Cash holdback - indemnity and working capital 1,122
Total purchase consideration $ 34,650